rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2008-2-27
|
pubmed:abstractText |
Many fractures occur in women with moderate fracture risk caused by osteopenia. Strontium ranelate was studied in 1431 postmenopausal women with osteopenia. Vertebral fracture risk reduction of 41-59% was shown depending on the site and fracture status at baseline. This is the first report of antivertebral fracture efficacy in women with vertebral osteopenia.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1523-4681
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
433-8
|
pubmed:meshHeading |
pubmed-meshheading:17997711-Aged,
pubmed-meshheading:17997711-Aged, 80 and over,
pubmed-meshheading:17997711-Female,
pubmed-meshheading:17997711-Humans,
pubmed-meshheading:17997711-Middle Aged,
pubmed-meshheading:17997711-Organometallic Compounds,
pubmed-meshheading:17997711-Osteoporosis, Postmenopausal,
pubmed-meshheading:17997711-Prevalence,
pubmed-meshheading:17997711-Risk Factors,
pubmed-meshheading:17997711-Spinal Fractures,
pubmed-meshheading:17997711-Spine,
pubmed-meshheading:17997711-Thiophenes,
pubmed-meshheading:17997711-Time Factors
|
pubmed:year |
2008
|
pubmed:articleTitle |
Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia.
|
pubmed:affiliation |
Austin Health, University of Melbourne, Melbourne, Australia. egos@unimelb.edu.au
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|